AMPH peer analysis
Amphastar Pharmaceuticals (AMPH) against its competitors: price, today's move, 1-year return and market value side by side.
AMPH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMRX Amneal | $20.44 | -4.97% | 104.40% | $7.49B |
| AYTU Aytu BioPharma | $1.93 | -2.53% | -12.67% | $20.97M |
| BHC Bausch Health | $8.26 | 0.67% | 24.89% | $3.07B |
| COLL Collegium | $23.63 | -0.71% | -33.72% | $774.82M |
| CPHI China Pharma | $0.62 | -3.86% | -64.81% | $26.88M |
| ETON Eton Pharmaceuticals | $51.03 | -2.20% | 179.62% | $1.49B |
| RDY Dr. Reddy's Laboratories | $14.09 | -0.56% | 4.76% | $11.80B |
| TEVA Teva | $41.13 | -2.28% | 105.34% | $49.09B |
| VTRS Viatris | $18.80 | -1.23% | 81.47% | – |
| AMPH Amphastar Pharmaceuticals | $27.72 | 2.93% | 12.41% | $1.18B |
- AMPH's peers: AMRX (Amneal), AYTU (Aytu BioPharma), BHC (Bausch Health), COLL (Collegium), CPHI (China Pharma), ETON (Eton Pharmaceuticals), RDY (Dr. Reddy's Laboratories), TEVA (Teva).
Updated 2026-11-02 17:14 UTC